BCEL - Atreca, Inc.
NASDAQ
->
Healthcare
->
Biotechnology
South San Francisco,
United States
Type: Equity
BCEL price evolution
BCEL
| (in millions $) | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 | 31 Jan 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $13.47 | $27.69 | $39.48 | $30.82 |
| Short term investments | $7.92 | $10.85 | $16.9 | $39.68 |
| Net receivables | $0.5 | $0.51 | $0.41 | $4.16 |
| Inventory | ||||
| Total current assets | $24.69 | $41.96 | $59.64 | $78.03 |
| Long term investments | ||||
| Property, plant & equipment | $1.61 | $70.65 | $72.29 | $74.03 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $1.65 | $73.11 | $74.78 | $77 |
| Total investments | $7.92 | $10.85 | $16.9 | $39.68 |
| Total assets | $26.34 | $115.07 | $134.43 | $155.03 |
| Current liabilities | ||||
| Accounts payable | $4.06 | $1.14 | $1.4 | $1.74 |
| Deferred revenue | ||||
| Short long term debt | $1.28 | $3.77 | $3.65 | $3.54 |
| Total current liabilities | $15.58 | $12.01 | $14.07 | $16.29 |
| Long term debt | $58.39 | $59.39 | $60.33 | |
| Total noncurrent liabilities | $58.39 | $59.39 | $60.33 | |
| Total debt | $1.28 | $62.16 | $63.05 | $63.88 |
| Total liabilities | $15.58 | $70.39 | $73.46 | $76.62 |
| Shareholders' equity | ||||
| Retained earnings | -$533.34 | -$497.12 | -$477.93 | -$456.92 |
| Other shareholder equity | -$0 | $0 | -$0.03 | -$0.27 |
| Total shareholder equity | $10.76 | $44.67 | $60.97 | $78.41 |
| (in millions $) | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $30.82 | $94.75 | $60.79 | $157.95 |
| Short term investments | $39.68 | $22.29 | $179.3 | $14.66 |
| Net receivables | $4.16 | $0.32 | $0.9 | $0.4 |
| Inventory | ||||
| Total current assets | $78.03 | $122.37 | $249.12 | $176.12 |
| Long term investments | $31.04 | $10.8 | ||
| Property, plant & equipment | $74.03 | $43.02 | $19.83 | $5.77 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $77 | $77.69 | $22.94 | $19.6 |
| Total investments | $39.68 | $53.33 | $179.3 | $25.46 |
| Total assets | $155.03 | $200.06 | $272.06 | $195.72 |
| Current liabilities | ||||
| Accounts payable | $1.74 | $3.35 | $5.22 | $2.13 |
| Deferred revenue | ||||
| Short long term debt | $3.54 | |||
| Total current liabilities | $16.29 | $16.9 | $17.42 | $7.95 |
| Long term debt | $60.33 | $0 | $0.05 | |
| Total noncurrent liabilities | $60.33 | $28.23 | $12.59 | $0.82 |
| Total debt | $63.88 | $0 | $0.05 | |
| Total liabilities | $76.62 | $45.13 | $30.01 | $8.76 |
| Shareholders' equity | ||||
| Retained earnings | -$456.92 | -$359.77 | -$250.44 | -$164.11 |
| Other shareholder equity | -$0.27 | -$0.1 | $0.06 | $0.02 |
| Total shareholder equity | $78.41 | $154.93 | $242.06 | $186.95 |
| (in millions $) | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 | 31 Dec 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | $10.41 | $12.91 | $13.45 | $13.77 |
| Selling, general & administrative | $5.39 | $6.83 | $8.08 | $7.54 |
| Total operating expenses | $36.65 | $19.75 | $21.53 | $21.75 |
| Operating income | -$36.65 | -$19.75 | -$21.53 | -$21.75 |
| Income from continuing operations | ||||
| EBIT | -$36.22 | -$19.19 | -$21.01 | -$21.34 |
| Income tax expense | ||||
| Interest expense | ||||
| Net income | ||||
| Net income | -$36.22 | -$19.19 | -$21.01 | -$21.34 |
| Income (for common shares) | -$36.22 | -$19.19 | -$21.01 | -$21.34 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | $66.83 | $78.35 | $62.05 | $54.73 |
| Selling, general & administrative | $31.47 | $31.95 | $26.83 | $17.84 |
| Total operating expenses | $98.74 | $110.3 | $88.88 | $72.57 |
| Operating income | -$98.74 | -$110.3 | -$88.88 | -$72.57 |
| Income from continuing operations | ||||
| EBIT | -$97.16 | -$109.32 | -$86.33 | -$67.48 |
| Income tax expense | $0 | $0 | $0 | |
| Interest expense | $0 | $0 | $0.01 | |
| Net income | ||||
| Net income | -$97.16 | -$109.33 | -$86.33 | -$67.48 |
| Income (for common shares) | -$97.16 | -$109.33 | -$86.33 | -$67.48 |
| (in millions $) | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 | 31 Dec 2022 |
|---|---|---|---|---|
| Net income | -$36.22 | -$19.19 | -$21.01 | -$21.34 |
| Operating activities | ||||
| Depreciation | $1.38 | $1.73 | $1.73 | $1.8 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $2.3 | $2.86 | $3.22 | $3.18 |
| Total cash flows from operations | -$17.22 | -$17.98 | -$14.44 | -$15.43 |
| Investing activities | ||||
| Capital expenditures | -$0.06 | -$0.02 | -$0.08 | -$0.15 |
| Investments | $3.05 | $6.21 | $23.08 | $25.5 |
| Total cash flows from investing | $2.99 | $6.18 | $23 | $25.35 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.01 | $0 | $0.11 | |
| Net borrowings | ||||
| Total cash flows from financing | $0.01 | $0 | $0.11 | |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$14.22 | -$11.8 | $8.66 | $9.92 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Net income | -$97.16 | -$109.33 | -$86.33 | -$67.48 |
| Operating activities | ||||
| Depreciation | $7.08 | $4.55 | $2.38 | $1.7 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $16.89 | $16.88 | $12.48 | $6.06 |
| Total cash flows from operations | -$80.72 | -$60.92 | -$66.67 | -$58.54 |
| Investing activities | ||||
| Capital expenditures | -$0.89 | -$35.09 | -$5.03 | -$3.45 |
| Investments | $13.43 | $124.33 | -$153.97 | -$24.46 |
| Total cash flows from investing | $12.55 | $89.24 | -$159 | -$27.9 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $3.91 | $5.5 | $129.55 | $134.07 |
| Net borrowings | -$0 | -$0.05 | -$0.05 | -$0.05 |
| Total cash flows from financing | $3.9 | $5.45 | $128.87 | $131.17 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$64.27 | $33.76 | -$96.8 | $44.73 |
News
Fundamentals
| Market cap | $3.56M |
|---|---|
| Enterprise value | -$8.62M |
| Shares outstanding | 39.60M |
| Revenue | $0.00 |
|---|---|
| EBITDA | -$91.11M |
| EBIT | -$97.76M |
| Net Income | -$97.76M |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | -0.04 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | 0.09 |
| EV/EBIT | 0.09 |
| P/S ratio | N/A |
| P/B ratio | 0.33 |
| Book/Share | 0.27 |
| Cash/Share | 0.34 |
| EPS | -$2.47 |
|---|---|
| ROA | -90.75% |
| ROE | -200.73% |
| Debt/Equity | 0.98 |
|---|---|
| Net debt/EBITDA | -0.02 |
| Current ratio | 1.58 |
| Quick ratio | 1.58 |